HALOZYME THERAPEUTICS INC

CUSIP: 40637HAF6 Class: NOTE 1.000% 8/1

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,060,000 Value ($000) $1,406 Avg Close Range
Q3 2025
Shares 1,069,000 Value ($000) $1,505 Avg Close Range
Q2 2025
Shares 1,569,000 Value ($000) $1,788 Avg Close Range
Q1 2025
Shares 1,569,000 Value ($000) $2,013 Avg Close Range
Q4 2024
Shares 1,569,000 Value ($000) $1,697 Avg Close Range
Q3 2024
Shares 1,069,000 Value ($000) $1,273 Avg Close Range
Q2 2024
Shares 2,569,000 Value ($000) $2,855 Avg Close Range
Q1 2024
Shares 3,569,000 Value ($000) $3,475 Avg Close Range
Q4 2023
Shares 3,850,000 Value ($000) $3,579 Avg Close Range
Q3 2023
Shares 3,850,000 Value ($000) $3,598 Avg Close Range